Neurological Biomarkers Market Size

The global neurological biomarkers market was valued at USD 8.10 Billion in 2023 and is anticipated to grow at a CAGR of 11.8% from 2024 to 2033. Neurological biomarkers play a crucial role in diagnosing various diseases, including autism, Parkinson's disease, and depression. They encompass metabolomics as well as imaging-based, genomic-based, and proteomic-based markers.